The Related Factors With Resilience in Caregivers Whose Child With Leukemia

Condition 1. Children With ALL Are Still Alive and the Age of 18 Years of Age. Clinical Trial

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT01249781
• Other study ID #: DMR-99-IRB-191
• Status: Enrolling by invitation
• Phase: N/A
• First received: November 26, 2010
• Last updated: November 26, 2010
• Start date: September 2010

Study information

• Verified date: November 2010
• Source: China Medical University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: The Institutional Review Bord China Medical University Hospital
• Study type: Observational

Clinical Trial Summary

The purpose of this study was to explore caregivers stress, family functioning, social support and family resilience of families whose children had acute lymphoblastic leukemia. The significantly correlation among caregivers stress, family functioning, social support and family resilience was also explored.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 50
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A to 18 Years

Eligibility

Inclusion Criteria:

1. Diagnosed as acute lymphoblastic leukemia children, children with cancer are still alive and the age of 18 years of age.

2. Has been completed to guide the treatment regimen were in remission.

3. Caregiver can or Taiwanese language communicator.

Exclusion Criteria:

• Children with metastatic cancer who end chemical treatment of more than one year

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Condition 1. Children With ALL Are Still Alive and the Age of 18 Years of Age.
• Condition 2. Has Been Completed to Guide the Treatment Regimen Were in Remission.
• Condition 3. Caregiver Can or Taiwanese Language Communicator.
• Disease

Locations

Country	Name	City	State
Taiwan	China Medical University Hospital	Taichung	No.2 Yuh Der Road

Sponsors (1)

Lead Sponsor	Collaborator
China Medical University Hospital

Country where clinical trial is conducted

Taiwan,